CurifyLabs is a health tech company transforming personalized medicine in pharmacies and hospitals by automating pharmaceutical compounding. Its Compounding System Solution (CSS) replaces manual, time-intensive processes with a streamlined, accurate platform for non-sterile dosage forms, including tablets, troches, films, liquids, suppositories, and capsules. Already used across Europe and the USA, CSS improves patient outcomes and pharmacy efficiency. Developed with pharmacists and backed by over a decade of academic research, CSS is inspired by 3D printing and designed to address workforce shortages, cost pressures, and regulatory requirements, while aligning with FDA 503A/503B standards. The system integrates a digital platform with validated formularies and quality documentation, GMP-manufactured IP-protected CuraBlend® excipient bases, and robotics automating the workflow from prescription to finished product. CSS enables tailored therapies by adjusting dose, shape, taste, and release profile, supports combination therapies, and offers multiple dosage forms. Built-in quality controls reduce errors, regulatory burden, and contamination risk, while automation increases speed up to fourfold and improves staff safety. Validated by over 30 pharmacists and adopted in 14+ markets, CSS is designed by pharmacists for pharmacists and fully compliant with U.S. compounding regulations.